insulin

Study shows insulin injections more than double risk of death in Type II diabetics

Wednesday, March 27, 2013 by: Ethan A. Huff, staff writer
Tags: insulin, diabetes, death risk

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
NJ cops bust teenagers shoveling snow without a permit
Chemotherapy kills cancer patients faster than no treatment at all
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students
Inuit Elders tell NASA Earth Axis Shifted
Vaccine flu shots still contain 25 micrograms mercury - 100 times the concentration of 'mercury-loaded' fish
Measles outbreak likely caused by vaccinated children, science shows
Baby formula is loaded with GMOs - Avoid these brands
Extreme trauma from male circumcision causes damage to areas of brain
Terminal stage IV lung cancer patient miraculously cured by cannabis oil
Costco stops selling antibiotic laden chicken in response to consumer demand
FDA cracks down Walmart, GNC, other companies selling supplements that do not contain the herbs on the label
McDonald's french fries found to contain Silly Putty ingredient and petroleum chemical

Delicious
(NaturalNews) According to the World Diabetes Foundation, nearly one-third of all Type II diabetics take daily insulin injections as part of their prescribed treatment protocol. But a new study published in The Journal of Clinical Endocrinology & Metabolism reveals that this quintessential diabetes therapy option may be responsible for more than doubling the risk of death from all causes among those with Type II diabetes.

Compiled by researchers from the U.K., the new study involved carefully scrutinizing the safety of insulin injections in order to gain a more thorough understanding of the treatment's many possible side effects. Utilizing data from the U.K. General Practice Research Database, which included nearly 85,000 patients with Type II diabetes, researchers compared the side effects of insulin injections alone with four other common treatment protocols for the disease.

Using metformin monotherapy as the baseline referent, the research team discovered that the risk of having a major cardiac event, developing a first cancer, or dying jumped by more than 30 percent when insulin was simply added to metformin treatment for Type II diabetes. Sulfonylurea monotherapy was found to be associated with a roughly 44 percent increased risk of these same conditions, while insulin monotherapy alone was associated with an overall 80 percent increased risk.

Compared to metformin monotherapy, sulfonylurea monotherapy, metformin plus sulfonylurea combination therapy, and insulin plus metformin combination therapy, insulin monotherapy was found to increase the risk of both stroke and cancer by about 43 percent, and major adverse cardiac events by about 74 percent. And while risk of myocardial infarction almost doubles while on insulin monotherapy, risk of neuropathy more than doubles, according to the figures.

The biggest jump was found with renal complications; however, which are three-and-a-half times more likely to occur as a result of insulin monotherapy. And risk of all-cause mortality more than doubles as a result of insulin monotherapy, illustrating the severe risk factors associated with taking this commonly-prescribed diabetes medication.

"In people with T2DM (Type II diabetes mellitus), exogenous insulin therapy was associated with an increased risk of diabetes-related complications, cancer, and all-cause mortality," wrote the authors in their conclusion. "There is a clear need to review the way in which exogenous insulin is used in people with Type II diabetes and to establish in detail the risk-benefit profile at differing stages of the natural history of the disease and in phenotypically different subgroups.

You can view the study abstract for yourself here:
http://jcem.endojournals.org/content/98/2/668

You can also learn more about how to cure diabetes naturally, without drugs, by visiting:
http://www.naturalnews.com/030150_diabetes_Americans.html

Sources for this article include:

http://jcem.endojournals.org/content/98/2/668

http://www.healio.com

http://www.cpmedical.net

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.